| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.322 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCC1=CNC2=CC=CC=C12
InChI
InChIKey=LSSUMOWDTKZHHT-UHFFFAOYSA-N
InChI=1S/C14H20N2/c1-3-16(4-2)10-9-12-11-15-14-8-6-5-7-13(12)14/h5-8,11,15H,3-4,9-10H2,1-2H3
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.322 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
PubMed
|
|
TARGET->WEAK AGONIST |
Hallucinogenic, 31% of the stimulation of 5-hydroxytryptamine. Stimulation of phosphoinositide hydrolysis.
EC50
1258 NANOMOLAR (average) |
Showing 1 to 1 of 1 entries
